Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 22
239
Views
0
CrossRef citations to date
0
Altmetric
Short Communications

Chemical composition, antibacterial and antioxidative activities of Monotheca buxifolia (Falc.) A. DC leaves essential oil

, , & ORCID Icon
Pages 5848-5851 | Received 22 Sep 2021, Accepted 05 Dec 2021, Published online: 23 Dec 2021
 

Abstract

Monotheca buxifolia (Sapotaceae) is used against different heath aliments due to auspicious biological properties. Essential oil was extracted from leaves of M. buxifolia through steam distillation. Gas chromatography coupled with mass spectrometry (GC-MS) showed presence of 34 compounds. Geranyl acetone (12.6%), nonanal (9.0%) and champhor (8.0%) were abundant while (E)-β-ionone, cis-carvone oxide and caryophyllene oxide were also found. The oil presented 50.2% free radical scavenging activity while total antioxidant potential and total reducing power potential were 40.0 µg AAE/mL and 38.7 µg AAE/mL, respectively. The extracted oil presented moderate activity against Escherichia coli (14 mm) and Bacillus subtilis (11 mm). The study concludes that the essential oil of M. buxifolia leaves has diverse chemical composition and biological activities therefore can be explored for therapeutic potential.

Graphical Abstract

Disclosure statement

Authors declare no conflict of interest.

Additional information

Funding

The research work was funded by Higher Education Commission, Pakistan under Indigenous PhD Fellowship program to Miss Joham Sarfraz Ali.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.